Moneycontrol PRO
you are here: HomeNewsBusiness

LG Chem halts lithium-ion battery project in India: Report

Batteries from the project were to be supplied for electric vehicles of Hyundai, M&M, Renault and M&M’s South Korean subsidiary Ssangyong.

May 21, 2020 / 04:00 PM IST

LG Chem has halted plans for its lithium-ion battery project in India as the auto sector reels under the ongoing coronavirus pandemic.

The company was in talks with Renault, Mahindra & Mahindra and Hyundai for an Indian consortium for the project and regarding equity participation for the same, sources told The Economic Times. LG Chem stated the project was announced in 2018.

Batteries from the project were to be supplied for electric vehicles of Hyundai, M&M, Renault and M&M’s South Korean subsidiary Ssangyong.

Stating that India is still at the “beginning stage of exploring demand of lithium-ion battery for EV”, and LG Chem executive told the publisher there is no “tangible information on the progress of the investment plan.”

Moneycontrol could not independently verify the report.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Mahesh Babu, CEO of Mahindra Electric told the paper that discussions on the project were detailed, but this has now “gone under the carpet”. “We have no idea on when this project will revive,” he said.

Industry experts however also believe that COVID-19 notwithstanding, India needs clearer battery storage policy with better incentives, higher localisation and reduced import tariffs.

Follow our full COVID-19 coverage here
Moneycontrol News
first published: May 21, 2020 03:50 pm
ISO 27001 - BSI Assurance Mark